The International Journal of Tuberculosis and Lung Disease

Needles, haystacks and grails: the challenges and promise of tuberculosis vaccine trials [Editorial]
pp. 143-143(1)
Author: Schwartzman, Kevin

Managing malaria in tuberculosis patients on fluoroquinolone-containing regimens: assessing the risk of QT prolongation [Review article]
pp. 144-149(6)
Authors: Murphy, M. E.; Singh, K. P.; Laurenzi, M.; Brown, M.; Gillespie, S. H.

CCL2−2518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis [Review article]
pp. 150-156(7)
Authors: Feng, W-X.; Flores-Villanueva, P. O.; Mokrousov, I.; Wu, X-R.; Xiao, J.; Jiao, W-W.; Sun, L.; Miao, Q.; Shen, C.; Shen, D.; Liu, F.; Jia, Z-W.; Shen, A.

Tuberculosis contact investigation in a high-burden setting: house or household?
pp. 157-162(6)
Authors: Van Wyk, S. S.; Mandalakas, A. M.; Enarson, D. A.; Gie, R. P.; Beyers, N.; Hesseling, A. C.

Serial testing of Malaysian health care workers with QuantiFERON®-TB Gold In-Tube
pp. 163-168(6)
Authors: Rafiza, S.; Rampal, K. G.

Physicians' attitudes towards self-treatment of latent tuberculosis [Short communication]
pp. 169-171(3)
Authors: Bhanot, N.; Haran, M.; Lodha, A.; Paul, V.; Goswami, R.; Chapnick, E. K.

Factors influencing sex differences in numbers of tuberculosis suspects at diagnostic centres in Pakistan
pp. 172-177(6)
Authors: Khan, Mishal S.; Khan, M. S.; Sismanidis, C.; Godfrey-Faussett, P.

DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008
pp. 178-184(7)
Authors: Yen, Y-F.; Rodwell, T. C.; Yen, M-Y.; Shih, H-C.; Hu, B-S.; Li, L-H.; Shie, Y-H.; Chuang, P.; Garfein, R. S.

Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial
pp. 185-191(7)
Authors: Moyo, S.; Verver, S.; Hawkridge, A.; Geiter, L.; Hatherill, M.; Workman, L.; Ontong, C.; Msemburi, W.; Tameris, M.; Geldenhuys, H.; Mulenga, H.; Snowden, M. A.; Hanekom, W. A.; Hussey, G.; Mahomed, H.; South African Tuberculosis Vaccine Initiative Neonatal Study Team,

High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial [Short communication]
pp. 192-195(4)
Authors: Hesseling, A. C.; Kim, S.; Madhi, S.; Nachman, S.; Schaaf, H. S.; Violari, A.; Victor, T. C.; McSherry, G.; Mitchell, C.; Cotton, M. F.; IMPAACT P1041 Team,

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa
pp. 196-202(7)
Authors: Mukinda, F. K.; Theron, D.; van der Spuy, G. D.; Jacobson, K. R.; Roscher, M.; Streicher, E. M.; Musekiwa, A.; Coetzee, G. J.; Victor, T. C.; Marais, B. J.; Nachega, J. B.; Warren, R. M.; Schaaf, H. S.

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis [Short communication]
pp. 203-205(3)
Authors: Smith, S. E.; Kurbatova, E. V.; Cavanaugh, J. S.; Cegielski, J. P.

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications [Technical note]
pp. 206-208(3)
Authors: Van Rie, A.; Mellet, K.; John, M-A.; Scott, L.; Page-Shipp, L.; Dansey, H.; Victor, T.; Warren, R.

Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa
pp. 209-215(7)
Authors: Loveday, M.; Wallengren, K.; Voce, A.; Margot, B.; Reddy, T.; Master, I.; Brust, J.; Chaiyachati, K.; Padayatchi, N.

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
pp. 216-220(5)
Authors: Williamson, D. A.; Roberts, S. A.; Bower, J. E.; Vaughan, R.; Newton, S.; Lowe, O.; Lewis, C. A.; Freeman, J. T.

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis [Short communication]
pp. 221-223(3)
Authors: Pierre-Audigier, C.; Surcouf, C.; Cadet-Daniel, V.; Namouchi, A.; Heng, S.; Murray, A.; Guillard, B.; Gicquel, B.

Genetic polymorphisms in the P2X7 gene and its association with susceptibility to tuberculosis
pp. 224-229(6)
Authors: Singla, N.; Gupta, D.; Joshi, A.; Batra, N.; Singh, J.

Recovery of Mycobacterium tuberculosis from Löwenstein-Jensen media contaminated with other organisms [Technical note]
pp. 230-231(2)
Authors: Nagarajan, P.; Anbarasu, S.; Kumar, V.; Selvakumar, N.

In vitro reaction phenotyping studies on rifamycins to explain the auto-induction of rifabutin metabolism [Short communication]
pp. 232-234(3)
Authors: Prasad, B.; Singh, S.

Real-time PCR and Amplified MTD® for rapid detection of Mycobacterium tuberculosis in pulmonary specimens
pp. 235-239(5)
Authors: Chen, X.; Yang, Q.; Kong, H.; Chen, Y.

Using likelihood ratios to estimate diagnostic accuracy of a novel multiplex nested PCR in extra-pulmonary tuberculosis
pp. 240-247(8)
Authors: Vadwai, V.; Shetty, A.; Rodrigues, C.

Pre-transplant risk factors for tuberculosis after kidney transplant in an intermediate burden area
pp. 248-254(7)
Authors: Jung, J. Y.; Joo, D. J.; Lee, C-H.; Park, M. S.; Kim, Y. S.; Kim, M. S.; Kim, S. I.; Kim, S. K.; Chang, J.; Kang, Y. A.

Dairy food, calcium and vitamin D intake and prevalence of allergic disorders in pregnant Japanese women
pp. 255-261(7)
Authors: Miyake, Y.; Tanaka, K.; Okubo, H.; Sasaki, S.; Arakawa, M.

Clinical features of subjects with an isolated FEV₁ reduction
pp. 262-267(6)
Authors: Jung, Y. J.; Ra, S. W.; Lee, S-D.; Park, C. S.; Oh, Y-M.

Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran
pp. 268-272(5)
Authors: Heydari, G.; Talischi, F.; Tafti, S. F.; Masjedi, M. R.

Smoking cessation in older adults
pp. 273-278(6)
Authors: Jeremias, E.; Chatkin, J. M.; Chatkin, G.; Seibert, J.; Martins, M.; Wagner, M.

Tuberculin skin test conversions in hospital housekeepers [Correspondence]
pp. 279-279(1)
Authors: Jereb, John A.; Privett, Thomas D.; Pearson, Michele L.

Empirical tuberculosis treatment or improved diagnostics? [Correspondence]
pp. 280-280(1)
Authors: Manabe, Yukari C.; Worodria, William; Cobelens, Frank

In reply to `Empirical tuberculosis treatment or improved diagnostics?' [Correspondence]
pp. 280-281(2)
Authors: Lawn, Stephen D.; Harries, Anthony D.

Interferon-gamma release assay T-SPOT®.TB and HIV-related tuberculosis [Correspondence]
pp. 281-282(2)
Authors: Sattah, Martin V.; Aye, San San; Azen, Colleen; Kort, Jens J.; Escalante, Patricio; Jones, Brenda E.

Tolerance of moxifloxacin-containing regimens in the treatment of tuberculosis [Correspondence]
pp. 282-283(2)
Authors: Fung, Siu-Leung; Yan, See-Wan; Chau, Chi-Hung; Yew, Wing-Wai

Efficacy of utilising patient self-report of auditory complaints to monitor aminoglycoside ototoxicity [Correspondence]
pp. 283-283(1)
Authors: Ramma, Lebogang D.; Ibekwe, Titus S.

Erratum
pp. 284-284(1)